generics
FDA approves Beximco’s generic version of MSD’s allergy drug Periactin
April 25, 2019Sales and Marketing FDA, MSD, Periactin, allergy, generics, pharma
Bangladesh-based Beximco Pharma is celebrating following the decision from the FDA to approve its generic version of MSD’s antihistamine therapy …
Teva settles ‘pay-to-delay’ case with FTC
February 21, 2019Business Services, Sales and Marketing FTC, Teva, antitrust, drugs, generics, monopoly
Teva Pharmaceuticals has settled a dispute with the Federal Trade Commission (FTC) over three separate federal court antitrust lawsuits involving …
FDA approves Indian firm Alembic’s generic of Teva’s Diamox
February 20, 2019Research and Development ANDA, Alembic, Gujurat, US FDA, diamox, generics
The US FDA has approved Guajarati firm Alembic Pharmaceuticals generic version of Teva’s Acetazolamide sold under the brand name Diamox, …
FDA approves record breaking 971 generic drugs in 2018
January 10, 2019Manufacturing and Production FDA, approval, generic drugs, generics, regulation
The FDA approved a record 971 generic drugs in the 2018 fiscal year, giving the go-ahead to 110 generics in …
Generics firms investigated for their involvement in the ‘largest cartel in the history of the United States’
December 11, 2018Manufacturing and Production Dr Reddy's, Mylan, Teva, US, corruption, generics, price fixing, price-fixing, sun
At least 16 generic drugmakers are being investigated for their involvement in what has been described as the “largest cartel …
Akorn CEO resigns after $4.3bn Fresenius deal falls through
December 10, 2018Sales and Marketing Akorn, CEO, Fresenius, M&A, MA, Raj Rai, court, generics
The CEO of American generics firm Akorn Inc has stepped down following a ruling from the Delaware Supreme Court declaring …
FDA generics approvals up 90% compared to 2014
October 25, 2018Sales and Marketing FDA, Trump, generics, pharma
Continuing to build on its successes in toppling previous benchmarks, it has emerged that the FDA’s total number of generic …
Chanelle Pharma announces €86m investment over next five years
October 12, 2018Medical Communications Ireland, chanelle, generics, investment, research
Chanelle Pharmaceuticals, one of the largest Irish-owned pharmaceutical companies in Ireland, have announced an €86 million investment programme over the …
Trump signs trust-busting biosimilar bill into law
October 11, 2018Business Services, Sales and Marketing FTC, Trump, biosimilars, generics, us politics
President Donald J Trump has signed off a law which requires drugmakers and pharma firms to reveal the details of …
New hospital-led organisation aims to tackle drug pricing problem by manufacturing generic drugs
October 9, 2018Manufacturing and Production PhRMA, aha, generics, hospitals, non profit, non-profit, pharma
Seven organisations representing around 500 US hospitals have become the governing members of a newly established initiative aimed at reducing …
Gilead to release generic versions of hep C meds over a decade before patent expiry
September 28, 2018Medical Communications, Sales and Marketing Epclusa, Gilead, generics, harvoni, hepatitis C, pharma
Gilead has announced its intention to undercut itself by releasing generic versions of its blockbuster drugs for the treatment of …
Senate bill would save money and allow generics to reach market more quickly, according to CBO report
September 20, 2018Business Services, Medical Communications, Sales and Marketing CBO, Senate, US, biosimilars, generics, law, politics
The Congressional Budget Office (CBO) has said in a report that a bipartisan bill awaiting a vote in the senate …
Europe-wide policy could boost generics market, study suggests
September 5, 2018Research and Development Europe, generics, growth, markets, pharma
A Europe-wide policy covering the generic pharmaceutical market would facilitate significant growth in the pharmaceutical sector according to a new …
Top Ten most popular articles on Pharmafile.com this week
August 31, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Eisai, Medicare, Novartis, UK, brexit, generics, king bio, pharma, top ten
Eight months of 2018 down – where has the year gone? As we move from August into September, and a …
Generics could save US Medicare $1 billion per year
August 24, 2018Medical Communications Medicare, United States, branded, generics, marketing, savings
The United States national health insurance programme Medicare could have save $1 billion through the use of generic drugs according …
